Company information lookup

PHARMAUST LIMITED (PAA)

To develop its own drug discovery intellectual property as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PAA 0.010 0% 0.010 0.012 0.000 0.000 0.000 0

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

PHARMAUST LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PAA
Securities
Official Listing Date 5 October, 2001
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.pharmaust.com
Registered Office Address PO Box 661, NEDLANDS, WA, AUSTRALIA, 6909
Head Office Telephone 08 9386 4787
Head Office Fax 08 9389 1464
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Bryant Mclarty (Executive Chairman)
Mr Henry Gulev (Non Exec. Director)
Mr Sam Wright (Non Exec. Director)
Company Secretary Mr Sam Wright
Principal Activities To develop its own drug discovery intellectual property as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

PHARMAUST LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
14/05/2013   Appendix 3B & s708 Notice 13 PDF
14/05/2013   Completion of Share Placement 1 PDF
30/04/2013 asterix Appendix 4C - quarterly 5 PDF
30/04/2013 asterix PharmAust to acquire rights to 3 oncology product platforms 5 PDF
29/04/2013 asterix Trading Halt 2 PDF
18/02/2013 asterix Appendix 4D and Financial Report Dec 2012 17 PDF
18/01/2013 asterix Appendix 4C - quarterly 5 PDF
05/12/2012   Change of Director's Interest Notice 2 PDF
05/12/2012   Amended Appendix 3B 8 PDF
05/12/2012   Appendix 3B 8 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
15 May 2013 0.010 -16.67% 0.010 0.010 1,000,000
07 May 2013 0.012 0% 0.012 0.011 2,247,833
03 May 2013 0.012 9.09% 0.012 0.011 589,667
02 May 2013 0.011 -8.33% 0.011 0.011 200,000
01 May 2013 0.012 -7.69% 0.012 0.011 3,534,094

* Volume of shares shown represents only those shares traded on ASX.

PHARMAUST LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PAA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PAA

Warrants & Structured Products

No warrants & Structured Products are available over the security PAA

ASX CFDs

No Contracts For Differences are available over the security PAA